Patent · US Active

Sitagliptin synthesis

US8846916B2 · kind B2 · utility

1Cited by
1References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 10, 2010
Grant dateSep 30, 2014
Priority date
Expiry dateMay 10, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/07
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to novel processes for the preparation of enantiomerically enriched β-amino acid derivatives such as β-amino esters useful for the synthesis of enantiomerically enriched biologically active molecules such as sitagliptin. The key step involves the resolution of the racemate with mandelic acid.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.